Skip to main content
VVT MED INC. logo

VVT MED INC. — Investor Relations & Filings

Ticker · VVTM ISIN · CA91841T1084 TSXV Manufacturing
Open in API
Filings indexed 362 across all filing types
Latest filing 2024-05-29 Regulatory Filings
Country CA Canada
Listing TSXV VVTM

About VVT MED INC.

https://www.vvtmed.com/

VVT MED INC. develops, manufactures, and commercializes minimally invasive, non-thermal, non-tumescent (NT-NT) solutions for the treatment of varicose veins and chronic venous disorders. The company's technology centers on the ScleroSafe Platform, a patented delivery system for Endovenous Chemical Ablation (ECA). ScleroSafe is designed to simplify procedures, shorten treatment times, and minimize patient recovery compared to traditional surgical and ablation methods. Products like ScleroSafe and V-Block, which treats severely dilated Great Saphenous Vein conditions, offer enhanced safety and efficacy. The platform holds regulatory clearances including FDA 510(k) and CE approval.

Recent filings

Filing Released Lang Actions
Interim MD&A - English.pdf
Regulatory Filings
2024-05-29 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 95% confidence The document is a Form 13-501F1 related to participation fees for reporting issuers, including a management certification by the CFO. It contains market value calculations for equity securities over specified trading periods and fee calculations. The document is primarily a regulatory filing submitted to the Alberta Securities Commission, certifying the accuracy of the information provided. It does not contain financial statements, earnings data, or detailed management discussion. The document length is 4440 characters, which is relatively short and consistent with a certification or regulatory filing rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as it is a certification and fee submission form rather than a financial report or announcement of a report.
2024-03-09 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 100% confidence The document is a Form 13-502F1 submission to the Ontario Securities Commission, which is a management certification related to participation fees for reporting issuers. It contains officer certification by the CFO, market value calculations for quarterly trading periods, and fee calculations. There are no financial statements or substantive financial data typical of annual or interim reports. The document is primarily a regulatory filing with certification and fee calculation details, not a financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS).
2024-03-09 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1, which is a Certification of Annual Filings Venture Issuer Basic Certificate. It is signed by the CEO certifying the review and fair presentation of the annual filings for the financial year ended December 31, 2023. The text explicitly states it is a certification and does not contain the actual annual report or financial statements but rather attests to their accuracy and completeness. The document length is short (3131 characters), and it serves as an officer certification rather than the report itself. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than the actual Annual Report (10-K) or Management Reports (MDA).
2024-03-09 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV1, which is a Certification of Annual Filings Venture Issuer Basic Certificate. It is signed by the CFO certifying the review and fair presentation of the annual filings for the financial year ended December 31, 2023. The document does not contain actual financial statements or detailed financial data but is a certification letter regarding the annual filings. According to the Certification Rule, such officer certifications or attestations, even if referencing annual reports or filings, should be classified as Regulatory Filings (RNS) rather than the report itself (10-K or Annual Report). The document length is 3116 characters, which is relatively short and consistent with a certification letter rather than a full report.
2024-03-09 English
Annual MD&A - English.pdf
Management Reports Classification · 100% confidence The document is titled 'Management's Discussion and Analysis' (MD&A) for the year ended December 31, 2023, dated March 8, 2024. It contains detailed discussion of the company's operations, financial results, forward-looking statements, critical accounting estimates, internal controls, and quarterly and annual financial summaries. The content includes substantive financial data and analysis, not just an announcement or certification. The MD&A is a management report explaining financial results and business trends, which fits the definition of Management Reports (MDA).
2024-03-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.